Oncology

This page provides advice to members on which paediatric patient groups are considered to be clinically extremely vulnerable during the COVID-19 outbreak and at very high risk of severe illness from coming into contact with the virus. This updated RCPCH advice for clinicians is provided to help ...

CCLG offers funds and grants to researchers to help beat childhood cancer.

This scheme provides funding for biomarker assay development, validation and qualification where there is a clear line of sight to clinical implementation.

Our Pioneer Award funds innovative, higher risk ideas, from any discipline, that could revolutionise our understanding of cancer.

The Research Bursary provides short-term funding to allow clinicians and other health professionals to get involved in research projects early in their career.

Funding for clinical trainees to undertake a research project after completion of a PhD.

Funding to enable researchers to learn new skills through short term laboratory visits. Funding is also available to attend conferences where new research findings are presented.

The review was commissioned by the Chief Executive of NHS England to assist its Board in the evaluation of responses to a consultation undertaken in summer 2019 relating to a new draft service specification for children’s cancers.

Funds research, which proactively drives forward the development of more, better and less toxic treatment options, bringing them to the UK and Ireland for children fighting neuroblastoma.

Area of interest is lower GI/ bowel research in malignant and non-malignant, diagnostic or treatment studies or device/intervention development for which future translation to tangible patient benefit can be anticipated.